Evidence map›Paper›PMID 41125092›Full record

ArticleBiomedical materials (Bristol, England)2025

Fabrication of polymer blend vascular grafts with enhanced mechanical properties and rapid cell infiltration: influence of micro/nanostructure, polymer composition, and post-processing on pore architecture and bioengineered environment.

Aurora Battistella, Morgan Linger, Richard D Johnson, Meredith Overton, Anna Sallee, Rajan Jain, Bridget Antreasian, Yifu Ding, Wei Tan

Abstract read
In one paragraph

Article in Biomedical materials (Bristol, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aurora BattistellaPaul M Rady Mechanical Engineering, University of Colorado at Boulder, Boulder, CO, United States of America.ORCID 0000-0002-0698-9521
Morgan LingerBiomedical Engineering Program, University of Colorado at Boulder, Boulder, CO, United States of America.
Richard D JohnsonPaul M Rady Mechanical Engineering, University of Colorado at Boulder, Boulder, CO, United States of America.ORCID 0000-0001-8321-284X
Meredith OvertonBiomedical Engineering Program, University of Colorado at Boulder, Boulder, CO, United States of America.ORCID 0009-0002-3529-6510
Anna SalleeBiomedical Engineering Program, University of Colorado at Boulder, Boulder, CO, United States of America.
Rajan JainPaul M Rady Mechanical Engineering, University of Colorado at Boulder, Boulder, CO, United States of America.ORCID 0000-0001-9045-1558
Bridget AntreasianBiomedical Engineering Program, University of Colorado at Boulder, Boulder, CO, United States of America.ORCID 0009-0000-2547-995X
Yifu DingPaul M Rady Mechanical Engineering, University of Colorado at Boulder, Boulder, CO, United States of America.
Wei TanPaul M Rady Mechanical Engineering, University of Colorado at Boulder, Boulder, CO, United States of America.ORCID 0000-0002-0831-1909

Funding

Synthetic Mesenchymal Stem Cell Niches for Vascular TherapyR01HL119371 · NHLBI · UNIVERSITY OF COLORADO · PI TAN, WEI · 2013 to 2023
$5.0M
NHLBI NIH HHS R01 HL119371
6 · The paper itself

Abstract

Arteriovenous (AV) shunts are critical conduits for patients with end-stage renal disease undergoing hemodialysis. Desired properties of next-generation AV graft materials include artery-like mechanics, clinically feasible manufacturing processes, and a bioactive interface that facilitates rapid and deep infiltration of neighboring cells to support tissue regeneration. These requirements inspired the design, fabrication, and post-processing of our constructs. In terms of material design, we evaluated the performance of three microfiber graft materials composed of a hydrophobic polymer and photo-clickable, 4-arm thiolated polyethylene glycol-norbornene (PEG-NB). The materials included two coaxially nanostructured fiber designs, each featuring a PEG-NB sheath and different cores-polycaprolactone (PCL) and PCL-co-lactic acid (PLCL), respectively-and a mixed composition created by directly blending the sheath and core solutions during electrospinning. For post-processing, the constructs were either air-dried or freeze-dried (FD). Surface morphology was assessed using scanning electron microscopy, while mechanical properties were characterized through tensile testing and dynamic mechanical analysis. Subcutaneous implants were evaluated at 1, 4, and 16 weeks using histological, immunofluorescent, and multiphoton microscopy analyses to examine cellular distribution, material structure, and tissue remodeling. Results showed that the freeze-drying post-processing method enhanced overall porosity, stiffness, and ultimate tensile strength. Among all tested conditions, the FD core-sheath structure with PCL most closely matched the mechanical properties of native vessels. Using PLCL as a core material increased degradation and cell infiltration during the first month of subcutaneous studies. Ultimately, graft strength, porosity, and bioactivity were effectively modulated by the choice of core material and post-processing method. These findings provide insights into tailoring electrospun PEG-NB hybrid constructs as candidate AV shunt grafts, highlighting opportunities to balance mechanical performance, degradation, and bioactivity for end-stage renal disease patients requiring durable hemodialysis access.

Indexed as

Blood Vessel ProsthesisNanostructuresPolymersAnimalsBiocompatible MaterialsHumansHydrophobic and Hydrophilic InteractionsMaterials TestingPolyestersPolyethylene GlycolsPorosityProsthesis DesignRenal DialysisTensile StrengthTissue EngineeringTissue ScaffoldsBiocompatible MaterialspolycaprolactonePolyestersPolyethylene GlycolsPolymerscell infiltrationmicrofibervascular graft

Identifiers

PMID41125092
PMCPMC12576255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.